MedPath

A study to check the safety and feasibility of Laryngeal Mask Airways with wide gastric port for Trans-esophageal Echocardiography guided cardiac catheterisation procedures.

Not Applicable
Completed
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2022/12/047811
Lead Sponsor
Dr Sanjeeta Rajendra Umbarkar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

I.Patients posted for percutaneous device closure procedures under TEE guidance.

II.Mouth opening >35mm.

III.Mallampati score 1or2

IV.Weight >30 kg.

V.Strict NBM.

Exclusion Criteria

I.Hemodynamically unstable.

II.Patient at risk of aspiration.

III.Difficult intubation.

IV.Edentulous.

V.Surgery duration >3hrs.

VI.Significant acute or chronic lung disease

VII.Known airway problems.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To check feasibility and safety of second generation LMA with wide gastric port in ease of TEE probe placement and efficient airway management of patients in percutaneous device closure procedures requiring TEE.Timepoint: From start of procedure to 24hrs post procedure in ICU.
Secondary Outcome Measures
NameTimeMethod
1)To observe success rate of TEE probe insertion. <br/ ><br>2)To observe success rate of LMA insertion. <br/ ><br>3)To observe ease of LMA insertion. <br/ ><br>4)To note presence of sore throat after LMA removal. <br/ ><br>5)To note visualisation of blood on the LMA after removal. <br/ ><br>6)To note any airway compromise after LMA removal. <br/ ><br>7)To note post-operative laryngospasm <br/ ><br>8)To note damage to Trans esophageal echocardiography probe.Timepoint: From start of procedure to 24hrs post procedure in ICU.
© Copyright 2025. All Rights Reserved by MedPath